EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 310 filers reported holding EDITAS MEDICINE INC in Q1 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $78 | -17.9% | 10,719 | 0.0% | 0.00% | – |
Q4 2022 | $95 | -99.9% | 10,719 | 0.0% | 0.00% | – |
Q3 2022 | $131,000 | -92.6% | 10,719 | -92.9% | 0.00% | -100.0% |
Q2 2022 | $1,774,000 | +108.5% | 149,930 | +235.2% | 0.01% | +150.0% |
Q1 2022 | $851,000 | -28.4% | 44,723 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,188,000 | -38.7% | 44,723 | +30.7% | 0.00% | -50.0% |
Q2 2021 | $1,938,000 | +35.0% | 34,208 | 0.0% | 0.00% | +33.3% |
Q1 2021 | $1,436,000 | -46.8% | 34,208 | -11.2% | 0.00% | -50.0% |
Q4 2020 | $2,701,000 | +149.9% | 38,530 | 0.0% | 0.01% | +100.0% |
Q3 2020 | $1,081,000 | -4.9% | 38,530 | -24.4% | 0.00% | -40.0% |
Q1 2017 | $1,137,000 | – | 50,941 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |